IP vs MXCT
International Paper (IP) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the IP and MXCT stock pages for the full models.
Not investment advice.